We have read with great interest the article entitled "Travel Vaccines: Update for Canadian Pharmacists" published in the November/December issue of the Canadian Pharmacists Journal. We share the author's view that pharmacists are in a unique position to provide guidance on safe and healthy travel practices, including immunization and personal protective measures. However, to do so, pharmacists must have access to the most accurate information. To this end, please allow us to provide some comments and clarifications regarding the approved product information for both the cholera/enterotoxigenic Escherichia coli (ETEC)-diarrhea vaccine (DUKORAL) and the Japanese encephalitis vaccine (IXIARO).